Serotain is an herbal remedy that supports serotonin secretion, a neurotransmitter essential to the well functioning of the human brain. Serotonin is believed to contribute to the general well-being and to determine feeling of happiness. Serotonin is also related to sleep processes, motor functions and other mental and affective functions.
The product is promoted as an appetite suppressant, mood elevator and a sleep aid and is based on a proprietary formula Griffonia extract (from a west African medicinal plant) and other natural ingredients.
The manufacturing company is Benchmark Botanicals (part of Triarco Industries), a producer of various herbal and dietary supplement targeting different health conditions.
Serotain was discontinued by the manufacturer for unknown reasons.
Serotain includes the following ingredients: 5-HTP, Gelatin, Magnesium, Griffonia simplicifolia extract, Rice Powder.
The product is a mixture of the 5-HTP amino-acid, plant extracts and magnesium. The formula is based on a main plant ingredient of African origin called Griffonia, a plant whose seeds are known to be an important source of 5-hydroxytryptophan (5-HTP). 5-HTP is a natural occurring amino acid and a chemical precursor. It is a metabolic intermediate in the biosynthesis of the Serotonin secretion.
It should be mentioned that 5-HTP has not been thoroughly studied in a clinical setting, therefore possible side effects and interactions with other drugs are not known. Little is also known on the Griffonia plant extract.
Due to the fact that the product is discontinued, little information is still available.
- The product used to receive rather good reviews.
- No research on the drug or on the product
- The product has been discontinued.
Serotain was discontinued, so long term treatment is not an option. The availability of the product from different retailers is also an aspect which should be taken into consideration before starting treatment. Furthermore, the benefit claims of the manufacturer are not backed up by empirical evidence.
We do not recommend starting treatment under these conditions.